Elan Announces First European Commission Approval of Injectable Treatment Using Elan’s NanoCrystal Technology

Elan Drug Technologies (EDT), the leading drug delivery unit of Elan Corporation, plc, announced that the first injectable product using EDT's NanoCrystal technology has been approved by the European Commission.

Related Posts

Comments are closed.